Tardive dystonia under risperidone treatment: A case of torticolis;Dystonie tardive sous risperidone: A propos d'un cas de torticolis

Encephale

Volumn 24, Issue 6, 1998, Pages 581-583

  Fdhil, H ^a   Krebs, M O ^a   Bayle, F ^a   Vanelle, J M ^a   Olie, J P ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

Anticholinergic; Atypical neuroleptics; Clozapine; Risperidone; Tardive dystonia

Indexed keywords

RISPERIDONE; NEUROLEPTIC AGENT;

ARTICLE; CASE REPORT; DYSTONIA; HUMAN; REMISSION; SCHIZOPHRENIA; TARDIVE DYSKINESIA; TREATMENT OUTCOME; ADULT; CHEMICALLY INDUCED DISORDER; DEPRESSION; MALE; TIME; TORTICOLLIS;

ADULT; ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER; DYSTONIA; HUMANS; MALE; RISPERIDONE; TIME FACTORS; TORTICOLLIS;

EID: 0032426436     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. BECHER M, BURKS E. Long-term safety of Risperidone : results of seven one-year trials. Annual Meeting of the American College of Clinical Pharmacology 1996.
2. BURKE RE, FAHN S, JANCOVIC J et al. Tardive dystonia : late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 1982 ; 32 : 1335-46.
3. CHOUINARD G. Effets of Risperidone in tardive dyskinesia : an analysis of the canadian multicenter Risperidone study. Journal of Clinical Pharmacology 1995 ; 15 (Suppl 1) : 36S-44.
4. DANNON PN, GRUNHAUS L, IANCU I et al. Vitamine E treatment in tardive dystonia. Clinical Neuropharmacology 1997 ; 20 : 434-7.
5. DAVID GC, OWEN S. Extrapyramidal side effects and tolerability of Risperidone : a review. J Clin Psychiatry 1994 ; 55 : 29.
6. KANG UJ, BURKE RE, FAHN S. Tardive dystonia. Adv Neural (US) 1988 ; 50 : 415-99.
7. POSTOLACHE TT, LONDONO JH, GHALEM R et al. Electroconvulsive Therapy in Tardive Dystonia. Convulsive Therapy 1995 ; 11 : 275-9.
8. RAJA M, AZZONI A. Tardive dystonia : prevalence, risk-factors and clinical features. Ital J Neurol 1996 ; 17 : 409-18.
9. RAJAM M. Tardive dystonia : prevalence, risk factors, and comparison with tardive dyskinesia in a population of 200 acute psychiatric inpatients. Euro Arch Pyschiatry Clin Neurosci 1995; 245 : 145-51.
10. SHAPLESKE J, McKAY AP, MICKENNA PJ. Successful treatment of tardive dystonia with clozapine and clonazepam. British Journal of Pyschiatry 1996 ; 168 : 516-8.
11. TARSY D, KAUFMAN D, SETHI KD et al. An open-label study of botulinum toxine A for treatment of tardive dystonia. Clinical Neuropharmacology 1997 ; vol. 20 (1) : 90-3.
12. VAN HARTEN PN, KAMPHIUS DJ, MATROOS GE. Use of clozapine in tardive dystonia. Prog Neuro-Psychopharmacol et Biol Psychiat 1996 ; vol. 20 : 263-74.
13. WOJCIK JD, FALK WE, FINK JS et al. A review of 32 cases of tardive dystonia. Am J Psychiatry 1991 ; 148 : 1055-9.